Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ronfani L"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Publisher Correction: Understanding Factors Leading to Primary Cesarean Section and Vaginal Birth After Cesarean Delivery in the Friuli-Venezia Giulia Region (North-Eastern Italy), 2005-2015.
Autorzy:
Cegolon L; Institute for Maternal & Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy. l..; Local Health Unit N.2 'Marca Trevigiana', Public Health Department, Treviso, Italy. l..
Mastrangelo G; Padua University, Department of Cardio-Thoracic & Vascular Sciences, Padua, Italy.
Maso G; Institute for Maternal & Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Dal Pozzo G; Hospital 'Villa Salus', Obstetric & Gynecology Unit, Venice, Italy.
Ronfani L; Institute for Maternal & Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Cegolon A; University of Macerata, Department of Political Sciences, Comunication and International Relationships, Macerata, Italy.
Heymann WC; Florida Department of Health, Sarasota County Health Department, Sarasota, Florida, USA.; Florida State University, College of Medicine, Department of Clinical Sciences, Sarasota, Florida, USA.
Barbone F; Institute for Maternal & Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 17; Vol. 11 (1), pp. 6705. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji:
Published Erratum
Tytuł:
National burden of cancer in Italy, 1990-2017: a systematic analysis for the global burden of disease study 2017.
Autorzy:
Bosetti C; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, 20156, Milan, Italy. .
Traini E; Clinical Epidemiology and Public Health Research Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Alam T; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Allen CA; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Carreras G; Oncologic Network, Prevention, and Research Institute, Florence, Italy.
Compton K; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Fitzmaurice C; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.; Division of Hematology, University of Washington, Seattle, WA, USA.
Force LM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Gallus S; Department of Environmental Health Sciences, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Gorini G; Oncologic Network, Prevention, and Research Institute, Florence, Italy.
Harvey JD; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Kocarnik JM; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
La Vecchia C; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Lugo A; Department of Environmental Health Sciences, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Naghavi M; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Pennini A; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Piccinelli C; CPO Piemonte, AOU Città Della Salute E Della Scienza, Torino, Italy.
Ronfani L; Clinical Epidemiology and Public Health Research Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Xu R; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Monasta L; Clinical Epidemiology and Public Health Research Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Dec 16; Vol. 10 (1), pp. 22099. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost of Illness*
Neoplasms/*epidemiology
Neoplasms, Germ Cell and Embryonal/*epidemiology
Testicular Neoplasms/*epidemiology
Adult ; Aged ; Early Detection of Cancer ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Neoplasms/pathology ; Neoplasms, Germ Cell and Embryonal/pathology ; Quality-Adjusted Life Years ; Risk Factors ; Testicular Neoplasms/pathology
SCR Disease Name:
Testicular Germ Cell Tumor
Czasopismo naukowe
Tytuł:
Determinants of length of stay after cesarean sections in the Friuli Venezia Giulia Region (North-Eastern Italy), 2005-2015.
Autorzy:
Cegolon L; Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy. l..; Local Health Unit N. 2 'Marca Trevigiana', Public Health Department, Via Castellana 2, 31100, Treviso, Italy. l..
Mastrangelo G; Department of Cardio-Thoracic and Vascular Sciences & Public Health, Padua University, Padua, Italy.
Maso G; Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Pozzo GD; Obstetrics and Gynecology Unit, Hospital 'Villa Salus, Venice, Italy.
Heymann WC; Florida Department of Health, Sarasota County Health Department, Sarasota, FL, USA.; Department of Clinical Sciences, College of Medicine, Florida State University, Sarasota, FL, USA.
Ronfani L; Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Barbone F; Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Nov 06; Vol. 10 (1), pp. 19238. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Cesarean Section*
Length of Stay*
Maternal Age*
Patient Discharge*
Adult ; Cross-Sectional Studies ; Female ; Humans ; Infant, Newborn ; Italy ; Male ; Pregnancy
Czasopismo naukowe
Tytuł:
Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage?
Autorzy:
D'Adamo P
Guerci VI
Fabretto A
Faletra F
Grasso DL
Ronfani L
Montico M
Morgutti M
Guastalla P
Gasparini P
Pokaż więcej
Źródło:
European journal of human genetics : EJHG [Eur J Hum Genet] 2009 Mar; Vol. 17 (3), pp. 284-6. Date of Electronic Publication: 2008 Dec 03.
Typ publikacji:
Letter
MeSH Terms:
Heterozygote*
Connexins/*genetics
Epidermis/*anatomy & histology
Gene Frequency/*genetics
Connexin 26 ; Connexins/metabolism ; Epidermis/metabolism ; Hearing Loss/genetics ; Humans
Opinia redakcyjna
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies